nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—Nephropathy toxic—Mitoxantrone—sarcoma	0.0261	0.0261	CcSEcCtD
Cefotetan—Nephropathy toxic—Etoposide—sarcoma	0.0217	0.0217	CcSEcCtD
Cefotetan—Blood bilirubin increased—Thiotepa—sarcoma	0.0183	0.0183	CcSEcCtD
Cefotetan—Prothrombin level increased—Epirubicin—sarcoma	0.017	0.017	CcSEcCtD
Cefotetan—Colitis—Thiotepa—sarcoma	0.0166	0.0166	CcSEcCtD
Cefotetan—Aplastic anaemia—Dactinomycin—sarcoma	0.0162	0.0162	CcSEcCtD
Cefotetan—Blood bilirubin increased—Mitoxantrone—sarcoma	0.0158	0.0158	CcSEcCtD
Cefotetan—Prothrombin level increased—Doxorubicin—sarcoma	0.0157	0.0157	CcSEcCtD
Cefotetan—Phlebitis—Dactinomycin—sarcoma	0.0145	0.0145	CcSEcCtD
Cefotetan—Vaginal moniliasis—Epirubicin—sarcoma	0.0138	0.0138	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Epirubicin—sarcoma	0.0133	0.0133	CcSEcCtD
Cefotetan—Vaginal moniliasis—Doxorubicin—sarcoma	0.0128	0.0128	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Epirubicin—sarcoma	0.0128	0.0128	CcSEcCtD
Cefotetan—Phlebitis—Mitoxantrone—sarcoma	0.0126	0.0126	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Doxorubicin—sarcoma	0.0123	0.0123	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Doxorubicin—sarcoma	0.0118	0.0118	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.0112	0.0112	CcSEcCtD
Cefotetan—Thrombocytosis—Epirubicin—sarcoma	0.0112	0.0112	CcSEcCtD
Cefotetan—Phlebitis—Etoposide—sarcoma	0.0105	0.0105	CcSEcCtD
Cefotetan—Thrombocytosis—Doxorubicin—sarcoma	0.0104	0.0104	CcSEcCtD
Cefotetan—Pancytopenia—Thiotepa—sarcoma	0.0103	0.0103	CcSEcCtD
Cefotetan—Pancytopenia—Dactinomycin—sarcoma	0.0103	0.0103	CcSEcCtD
Cefotetan—Neutropenia—Dactinomycin—sarcoma	0.0101	0.0101	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00954	0.00954	CcSEcCtD
Cefotetan—Pancytopenia—Vincristine—sarcoma	0.00916	0.00916	CcSEcCtD
Cefotetan—Agranulocytosis—Thiotepa—sarcoma	0.00905	0.00905	CcSEcCtD
Cefotetan—Neutropenia—Vincristine—sarcoma	0.00902	0.00902	CcSEcCtD
Cefotetan—Agranulocytosis—Dactinomycin—sarcoma	0.00898	0.00898	CcSEcCtD
Cefotetan—Pancytopenia—Mitoxantrone—sarcoma	0.00892	0.00892	CcSEcCtD
Cefotetan—Neutropenia—Mitoxantrone—sarcoma	0.00879	0.00879	CcSEcCtD
Cefotetan—Haemoglobin—Thiotepa—sarcoma	0.00875	0.00875	CcSEcCtD
Cefotetan—Haemorrhage—Thiotepa—sarcoma	0.00871	0.00871	CcSEcCtD
Cefotetan—Erythema multiforme—Dactinomycin—sarcoma	0.00817	0.00817	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00814	0.00814	CcSEcCtD
Cefotetan—Agranulocytosis—Mitoxantrone—sarcoma	0.00782	0.00782	CcSEcCtD
Cefotetan—Haemoglobin—Mitoxantrone—sarcoma	0.00756	0.00756	CcSEcCtD
Cefotetan—Haemorrhage—Mitoxantrone—sarcoma	0.00752	0.00752	CcSEcCtD
Cefotetan—Pancytopenia—Etoposide—sarcoma	0.00742	0.00742	CcSEcCtD
Cefotetan—Blood bilirubin increased—Epirubicin—sarcoma	0.00738	0.00738	CcSEcCtD
Cefotetan—Neutropenia—Etoposide—sarcoma	0.00731	0.00731	CcSEcCtD
Cefotetan—Vaginal inflammation—Epirubicin—sarcoma	0.00698	0.00698	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00691	0.00691	CcSEcCtD
Cefotetan—Blood bilirubin increased—Doxorubicin—sarcoma	0.00683	0.00683	CcSEcCtD
Cefotetan—Leukopenia—Thiotepa—sarcoma	0.00679	0.00679	CcSEcCtD
Cefotetan—Leukopenia—Dactinomycin—sarcoma	0.00673	0.00673	CcSEcCtD
Cefotetan—Colitis—Epirubicin—sarcoma	0.0067	0.0067	CcSEcCtD
Cefotetan—Vaginal infection—Epirubicin—sarcoma	0.00659	0.00659	CcSEcCtD
Cefotetan—Convulsion—Thiotepa—sarcoma	0.00657	0.00657	CcSEcCtD
Cefotetan—Aplastic anaemia—Epirubicin—sarcoma	0.00656	0.00656	CcSEcCtD
Cefotetan—Agranulocytosis—Etoposide—sarcoma	0.0065	0.0065	CcSEcCtD
Cefotetan—Vaginal inflammation—Doxorubicin—sarcoma	0.00646	0.00646	CcSEcCtD
Cefotetan—Discomfort—Dactinomycin—sarcoma	0.00633	0.00633	CcSEcCtD
Cefotetan—Colitis—Doxorubicin—sarcoma	0.0062	0.0062	CcSEcCtD
Cefotetan—Vaginal infection—Doxorubicin—sarcoma	0.0061	0.0061	CcSEcCtD
Cefotetan—Aplastic anaemia—Doxorubicin—sarcoma	0.00607	0.00607	CcSEcCtD
Cefotetan—Thrombocytopenia—Thiotepa—sarcoma	0.00606	0.00606	CcSEcCtD
Cefotetan—Leukopenia—Vincristine—sarcoma	0.00602	0.00602	CcSEcCtD
Cefotetan—Thrombocytopenia—Dactinomycin—sarcoma	0.00601	0.00601	CcSEcCtD
Cefotetan—Erythema multiforme—Etoposide—sarcoma	0.00591	0.00591	CcSEcCtD
Cefotetan—Phlebitis—Epirubicin—sarcoma	0.00588	0.00588	CcSEcCtD
Cefotetan—Leukopenia—Mitoxantrone—sarcoma	0.00586	0.00586	CcSEcCtD
Cefotetan—Convulsion—Vincristine—sarcoma	0.00582	0.00582	CcSEcCtD
Cefotetan—Hepatic function abnormal—Epirubicin—sarcoma	0.0058	0.0058	CcSEcCtD
Cefotetan—Convulsion—Mitoxantrone—sarcoma	0.00567	0.00567	CcSEcCtD
Cefotetan—Discomfort—Mitoxantrone—sarcoma	0.00551	0.00551	CcSEcCtD
Cefotetan—Anaphylactic shock—Vincristine—sarcoma	0.00549	0.00549	CcSEcCtD
Cefotetan—Phlebitis—Doxorubicin—sarcoma	0.00544	0.00544	CcSEcCtD
Cefotetan—Thrombocytopenia—Vincristine—sarcoma	0.00537	0.00537	CcSEcCtD
Cefotetan—Hepatic function abnormal—Doxorubicin—sarcoma	0.00537	0.00537	CcSEcCtD
Cefotetan—Anaphylactic shock—Mitoxantrone—sarcoma	0.00534	0.00534	CcSEcCtD
Cefotetan—Thrombocytopenia—Mitoxantrone—sarcoma	0.00523	0.00523	CcSEcCtD
Cefotetan—Gastrointestinal pain—Thiotepa—sarcoma	0.00506	0.00506	CcSEcCtD
Cefotetan—Gastrointestinal pain—Dactinomycin—sarcoma	0.00502	0.00502	CcSEcCtD
Cefotetan—Urticaria—Thiotepa—sarcoma	0.00491	0.00491	CcSEcCtD
Cefotetan—Abdominal pain—Thiotepa—sarcoma	0.00489	0.00489	CcSEcCtD
Cefotetan—Body temperature increased—Thiotepa—sarcoma	0.00489	0.00489	CcSEcCtD
Cefotetan—Leukopenia—Etoposide—sarcoma	0.00487	0.00487	CcSEcCtD
Cefotetan—Abdominal pain—Dactinomycin—sarcoma	0.00485	0.00485	CcSEcCtD
Cefotetan—Body temperature increased—Dactinomycin—sarcoma	0.00485	0.00485	CcSEcCtD
Cefotetan—Convulsion—Etoposide—sarcoma	0.00472	0.00472	CcSEcCtD
Cefotetan—Discomfort—Etoposide—sarcoma	0.00458	0.00458	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00456	0.00456	CcSEcCtD
Cefotetan—Hypersensitivity—Thiotepa—sarcoma	0.00456	0.00456	CcSEcCtD
Cefotetan—Hypersensitivity—Dactinomycin—sarcoma	0.00452	0.00452	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vincristine—sarcoma	0.00449	0.00449	CcSEcCtD
Cefotetan—Anaphylactic shock—Etoposide—sarcoma	0.00444	0.00444	CcSEcCtD
Cefotetan—Pruritus—Thiotepa—sarcoma	0.00438	0.00438	CcSEcCtD
Cefotetan—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00437	0.00437	CcSEcCtD
Cefotetan—Thrombocytopenia—Etoposide—sarcoma	0.00435	0.00435	CcSEcCtD
Cefotetan—Eosinophilia—Epirubicin—sarcoma	0.00434	0.00434	CcSEcCtD
Cefotetan—Abdominal pain—Vincristine—sarcoma	0.00434	0.00434	CcSEcCtD
Cefotetan—Body temperature increased—Vincristine—sarcoma	0.00434	0.00434	CcSEcCtD
Cefotetan—Urticaria—Mitoxantrone—sarcoma	0.00424	0.00424	CcSEcCtD
Cefotetan—Diarrhoea—Thiotepa—sarcoma	0.00423	0.00423	CcSEcCtD
Cefotetan—Abdominal pain—Mitoxantrone—sarcoma	0.00422	0.00422	CcSEcCtD
Cefotetan—Body temperature increased—Mitoxantrone—sarcoma	0.00422	0.00422	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00422	0.00422	CcSEcCtD
Cefotetan—Diarrhoea—Dactinomycin—sarcoma	0.0042	0.0042	CcSEcCtD
Cefotetan—Pancytopenia—Epirubicin—sarcoma	0.00416	0.00416	CcSEcCtD
Cefotetan—Neutropenia—Epirubicin—sarcoma	0.0041	0.0041	CcSEcCtD
Cefotetan—Hypersensitivity—Vincristine—sarcoma	0.00404	0.00404	CcSEcCtD
Cefotetan—Eosinophilia—Doxorubicin—sarcoma	0.00401	0.00401	CcSEcCtD
Cefotetan—Hypersensitivity—Mitoxantrone—sarcoma	0.00394	0.00394	CcSEcCtD
Cefotetan—Vomiting—Thiotepa—sarcoma	0.00393	0.00393	CcSEcCtD
Cefotetan—Vomiting—Dactinomycin—sarcoma	0.0039	0.0039	CcSEcCtD
Cefotetan—Rash—Thiotepa—sarcoma	0.0039	0.0039	CcSEcCtD
Cefotetan—Dermatitis—Thiotepa—sarcoma	0.0039	0.0039	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00387	0.00387	CcSEcCtD
Cefotetan—Rash—Dactinomycin—sarcoma	0.00387	0.00387	CcSEcCtD
Cefotetan—Pancytopenia—Doxorubicin—sarcoma	0.00385	0.00385	CcSEcCtD
Cefotetan—Neutropenia—Doxorubicin—sarcoma	0.00379	0.00379	CcSEcCtD
Cefotetan—Diarrhoea—Vincristine—sarcoma	0.00375	0.00375	CcSEcCtD
Cefotetan—Nausea—Thiotepa—sarcoma	0.00367	0.00367	CcSEcCtD
Cefotetan—Diarrhoea—Mitoxantrone—sarcoma	0.00366	0.00366	CcSEcCtD
Cefotetan—Nausea—Dactinomycin—sarcoma	0.00365	0.00365	CcSEcCtD
Cefotetan—Agranulocytosis—Epirubicin—sarcoma	0.00364	0.00364	CcSEcCtD
Cefotetan—Gastrointestinal pain—Etoposide—sarcoma	0.00363	0.00363	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00358	0.00358	CcSEcCtD
Cefotetan—Urticaria—Etoposide—sarcoma	0.00353	0.00353	CcSEcCtD
Cefotetan—Haemoglobin—Epirubicin—sarcoma	0.00352	0.00352	CcSEcCtD
Cefotetan—Abdominal pain—Etoposide—sarcoma	0.00351	0.00351	CcSEcCtD
Cefotetan—Body temperature increased—Etoposide—sarcoma	0.00351	0.00351	CcSEcCtD
Cefotetan—Haemorrhage—Epirubicin—sarcoma	0.00351	0.00351	CcSEcCtD
Cefotetan—Vomiting—Vincristine—sarcoma	0.00349	0.00349	CcSEcCtD
Cefotetan—Rash—Vincristine—sarcoma	0.00346	0.00346	CcSEcCtD
Cefotetan—Dermatitis—Vincristine—sarcoma	0.00346	0.00346	CcSEcCtD
Cefotetan—Vomiting—Mitoxantrone—sarcoma	0.0034	0.0034	CcSEcCtD
Cefotetan—Agranulocytosis—Doxorubicin—sarcoma	0.00337	0.00337	CcSEcCtD
Cefotetan—Rash—Mitoxantrone—sarcoma	0.00337	0.00337	CcSEcCtD
Cefotetan—Dermatitis—Mitoxantrone—sarcoma	0.00337	0.00337	CcSEcCtD
Cefotetan—Erythema multiforme—Epirubicin—sarcoma	0.00332	0.00332	CcSEcCtD
Cefotetan—Hypersensitivity—Etoposide—sarcoma	0.00327	0.00327	CcSEcCtD
Cefotetan—Haemoglobin—Doxorubicin—sarcoma	0.00326	0.00326	CcSEcCtD
Cefotetan—Nausea—Vincristine—sarcoma	0.00326	0.00326	CcSEcCtD
Cefotetan—Haemorrhage—Doxorubicin—sarcoma	0.00324	0.00324	CcSEcCtD
Cefotetan—Nausea—Mitoxantrone—sarcoma	0.00317	0.00317	CcSEcCtD
Cefotetan—Pruritus—Etoposide—sarcoma	0.00314	0.00314	CcSEcCtD
Cefotetan—Erythema multiforme—Doxorubicin—sarcoma	0.00307	0.00307	CcSEcCtD
Cefotetan—Diarrhoea—Etoposide—sarcoma	0.00304	0.00304	CcSEcCtD
Cefotetan—Vomiting—Etoposide—sarcoma	0.00283	0.00283	CcSEcCtD
Cefotetan—Rash—Etoposide—sarcoma	0.0028	0.0028	CcSEcCtD
Cefotetan—Dermatitis—Etoposide—sarcoma	0.0028	0.0028	CcSEcCtD
Cefotetan—Leukopenia—Epirubicin—sarcoma	0.00273	0.00273	CcSEcCtD
Cefotetan—Convulsion—Epirubicin—sarcoma	0.00264	0.00264	CcSEcCtD
Cefotetan—Nausea—Etoposide—sarcoma	0.00264	0.00264	CcSEcCtD
Cefotetan—Discomfort—Epirubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Cefotetan—Leukopenia—Doxorubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Cefotetan—Anaphylactic shock—Epirubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Cefotetan—Convulsion—Doxorubicin—sarcoma	0.00245	0.00245	CcSEcCtD
Cefotetan—Thrombocytopenia—Epirubicin—sarcoma	0.00244	0.00244	CcSEcCtD
Cefotetan—Discomfort—Doxorubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Cefotetan—Anaphylactic shock—Doxorubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Cefotetan—Thrombocytopenia—Doxorubicin—sarcoma	0.00226	0.00226	CcSEcCtD
Cefotetan—Gastrointestinal pain—Epirubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Cefotetan—Urticaria—Epirubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Cefotetan—Abdominal pain—Epirubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Cefotetan—Body temperature increased—Epirubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Cefotetan—Gastrointestinal pain—Doxorubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Cefotetan—Hypersensitivity—Epirubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Cefotetan—Urticaria—Doxorubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Cefotetan—Body temperature increased—Doxorubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Cefotetan—Abdominal pain—Doxorubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Cefotetan—Pruritus—Epirubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Cefotetan—Diarrhoea—Epirubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Cefotetan—Hypersensitivity—Doxorubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Cefotetan—Pruritus—Doxorubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Cefotetan—Vomiting—Epirubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefotetan—Diarrhoea—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefotetan—Rash—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Cefotetan—Dermatitis—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Cefotetan—Nausea—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Cefotetan—Vomiting—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Cefotetan—Rash—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Cefotetan—Dermatitis—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Cefotetan—Nausea—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
